MarketsandMarkets Presents
Pharmaceutical Excipients Market worth 8.1 Billion USD by 2021
http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market956.html
The report "Pharmaceutical Excipients Market by Type 9Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), by Functionality (Filler, Binder, Lubricant, Preservative), & by Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021", The global pharmaceutical excipients market is expected to reach USD 8.1 Billion by 2021, at a CAGR of 6.1% from 2016 to 2021. Browse: 194 market data tables 46 figures 256 pages And in-depth TOC on DzPharmaceutical Excipients Marketdz
Download The PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=956 This report studies the pharmaceutical excipients market over the forecast period of 20162021.
http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
In this report, the pharmaceutical excipients market is segmented by product, delivery form, functionality, and region. It also discusses the key market trends, drivers, restraints,
challenges, and opportunities in this market and its submarkets. Talk To Our Research Experts@ http://www.marketsandmarkets.com/speaktoanalyst.asp?id=956 The growth of the market is attributed to the increasing demand for functionality excipients, recent patents expiries driving the demand for pharmaceutical excipients in generic drug manufacturing, advancements in nanotechnology, and the emergence of new excipients for the pharmaceutical industry. However, decline in the R&D investments
and increasing regulatory requirements are expected to hinder the market growth. http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
In 2015, Europe accounted for the largest share of the global pharmaceutical excipients market, followed by North America and Asia-Pacific. The presence of a large number of
pharmaceutical excipients manufacturers in the European and North American regions has led to their large shares in the pharmaceutical excipients market. However, the AsiaPacific region is projected to register the highest growth during the forecast period.
In 2015, the organic chemicals segment accounted for the largest share of the
pharmaceutical excipients market, followed by inorganic chemicals. The large share of organic chemicals can be attributed to the wide applications in the manufacturing of pharmaceutical drugs. http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
Amongst formulations, oral formulations accounted for the largest share of the pharmaceutical excipients market in 2015, owing to the shrinking pipeline of new chemical entities (NCEs), and focus on the development of orally disintegrating tablets (ODTs) and other novel methods of oral drug delivery. There is also a growing trend towards the formulation of sachets. Topical formulations are expected to grow at the highest CAGR during the forecast period.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF SE (Germany), The Dow Chemical Company (U.S.), Roquette (France), FMC
Corporation (U.S.), Evonik Industries AG (Germany), Associated British Foods Plc. (U.K.), Archer Daniels Midland Company (U.S.), Lubrizol Corporation (U.S.), and Croda International Plc. (U.K.).
http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
http://www.marketsandmarkets.com/Market-Reports/pharma-excipients-market-956.html
Contact Us Mr. Rohan MarketsandMarkets™ 701 Pike Street Suite 2175, Seattle, WA 98101, United States Tel: 1-888-600-6441 Email: sales@marketsandmarkets.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets